PKM and cancer: The binding of tyrosine-phosphorylated peptides to PKM2 at lysine-433 was found to inhibit PKM2 enzymatic activity through release of the allosteric activator fructose-1,6-bisphosphate (FBP) and to promote cell growth and glycolytic metabolism in cancer cells [40].